Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinicopathological and epigenetic differences between primary neuroendocrine tumors and neuroendocrine metastases in the ovary.
Mulders MC, Verschuur AVD, de Lussanet de la Sablonière QG, Roes EM, Geisenberger C, Brosens LA, de Herder WW, van Velthuysen MF, Hofland J. Mulders MC, et al. Among authors: de lussanet de la sabloniere qg. J Pathol Clin Res. 2024 Nov;10(6):e70000. doi: 10.1002/2056-4538.70000. J Pathol Clin Res. 2024. PMID: 39513463 Free PMC article.
Hybrid FDG-PET/MRI for Diagnosis and Clinical Management of Patients with Suspected Perihilar Cholangiocarcinoma: A Feasibility Pilot Study.
de Jong DM, Chehin K, Meijering TLN, Segbers M, van Driel LMJW, Bruno MJ, Groot Koerkamp B, IJzermans JNM, Verburg FA, de Lussanet de la Sabloniere QG, Dwarkasing RS. de Jong DM, et al. Among authors: de lussanet de la sabloniere qg. Nucl Med Mol Imaging. 2024 Oct;58(6):364-376. doi: 10.1007/s13139-024-00873-2. Epub 2024 Aug 1. Nucl Med Mol Imaging. 2024. PMID: 39308493 Free PMC article.
Evaluation of Hepatocellular Carcinoma Surveillance with Contrast-enhanced MRI in a High-Risk Western European Cohort.
Fiduzi FIF, Willemssen FEJA, de Braak CV, de Lussanet de la Sablonière QG, IJzermans JNM, Bos D, de Man RA, Dwarkasing RS. Fiduzi FIF, et al. Among authors: de lussanet de la sabloniere qg. Curr Probl Diagn Radiol. 2024 Nov-Dec;53(6):709-716. doi: 10.1067/j.cpradiol.2024.07.001. Epub 2024 Jul 9. Curr Probl Diagn Radiol. 2024. PMID: 39003123 Free article.
How to design a theranostic trial?
Siripongsatian D, de Lussanet de la Sablonière QG, Anton Verburg F, Brabander T. Siripongsatian D, et al. Among authors: de lussanet de la sabloniere qg. Endocr Oncol. 2024 May 10;4(1):e230045. doi: 10.1530/EO-23-0045. eCollection 2024 Jan 1. Endocr Oncol. 2024. PMID: 38770190 Free PMC article. Review.
18 F-FDG PET/MRI for restaging esophageal cancer after neoadjuvant chemoradiotherapy.
Valkema MJ, de Lussanet de la Sablonière QG, Valkema R, Thomeer MGJ, Dwarkasing RS, Harteveld AA, Doukas M, Mostert B, van der Zijden CJ, van der Sluis PC, Lagarde SM, Wijnhoven BPL, Verburg FA, van Lanschot JJB. Valkema MJ, et al. Among authors: de lussanet de la sabloniere qg. Nucl Med Commun. 2024 Feb 1;45(2):128-138. doi: 10.1097/MNM.0000000000001793. Epub 2023 Nov 20. Nucl Med Commun. 2024. PMID: 37982560